Larry E. Kun

Larry E. Kun's AcademicInfluence.com Rankings

Larry E. Kun

Philosophy

#7127

World Rank

#10290

Historical Rank

Logic

#4201

World Rank

#5462

Historical Rank

philosophy Degrees

Larry E. Kun

Biology

#9667

World Rank

#12897

Historical Rank

Biochemistry

#1489

World Rank

#1616

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Larry E. Kun's Degrees

Masters Medicine University of California, San Francisco
PhD Biochemistry University of California, San Francisco

Why Is Larry E. Kun Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Larry E. Kun's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Treating childhood acute lymphoblastic leukemia without cranial irradiation. (2009) (1051)
Late neurocognitive sequelae in survivors of brain tumours in childhood. (2004) (768)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. (2006) (761)
Radiation response of the central nervous system. (1995) (633)
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. (2004) (467)
Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. (2003) (421)
Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. (1998) (405)
Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. (2009) (395)
High incidence of secondary brain tumours after radiotherapy and antimetabolites (1999) (387)
Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. (2001) (371)
Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. (1998) (365)
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. (2005) (355)
Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001. (2002) (306)
Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. (2001) (303)
Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. (2005) (287)
Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. (2004) (276)
Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. (1986) (274)
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. (2000) (273)
Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. (2004) (268)
Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. (1992) (230)
Histopathologic grading of medulloblastomas (2002) (230)
There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. (1999) (222)
Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System: Report on Workshop (2002) (220)
Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. (1999) (216)
Neurocognitive deficits in medulloblastoma survivors and white matter loss (1999) (216)
Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. (1997) (213)
Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study (2013) (209)
Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. (1989) (209)
Common solid tumors of childhood. (1991) (206)
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study (2017) (206)
Brain stem gliomas: a classification system based on magnetic resonance imaging. (1990) (204)
Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. (2007) (194)
“Large Cell/Anaplastic” Medulloblastomas: A Pediatric Oncology Group Study (2000) (188)
Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. (2006) (187)
Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. (2010) (183)
Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study. (2015) (177)
The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. (1999) (173)
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. (2007) (171)
Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. (1997) (170)
Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. (2008) (169)
Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma. (2003) (167)
Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. (2001) (166)
Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. (1997) (162)
Quality of life in children treated for brain tumors. Intellectual, emotional, and academic function. (1983) (162)
Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. (1993) (159)
Primary Neurosurgery for Pediatric Low-Grade Gliomas: A Prospective Multi-Institutional Study From the Children's Oncology Group (2011) (158)
A retrospective study of surgery and reirradiation for recurrent ependymoma. (2008) (158)
Phase II trial of conformal radiation therapy for pediatric low-grade glioma. (2009) (157)
Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. (2003) (155)
Survival after recurrence of Ewing Tumors (2002) (153)
Treatment of intraocular retinoblastoma with vincristine and carboplatin. (2003) (152)
Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. (2008) (152)
Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. (1999) (149)
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study. (2011) (149)
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012. (2008) (143)
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment. (2003) (140)
Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. (2000) (138)
Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. (2005) (138)
Prognostic Factors in Infants and Very Young Children with Intracranial Ependymomas (1998) (135)
White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. (2004) (132)
Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. (1996) (128)
Response of recurrent medulloblastoma to low-dose oral etoposide. (1996) (123)
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study. (2014) (121)
Atypical white matter volume development in children following craniospinal irradiation. (2005) (121)
High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031). (2013) (120)
Survival and functional outcome of children with hypothalamic/chiasmatic tumors (2003) (118)
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium. (2011) (117)
Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies (2012) (116)
Increased mortality after successful treatment for Hodgkin's disease. (1998) (113)
Bone sarcomas of the head and neck in children (2000) (112)
Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. (1999) (111)
Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: A pediatric oncology group study (1998) (111)
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. (2008) (111)
Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. (2008) (109)
Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood (2004) (108)
Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. (2003) (108)
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007. (2012) (107)
CNS germinoma: disease control and long-term functional outcome for 12 children treated with craniospinal irradiation. (2000) (106)
Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control. (2001) (106)
VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. (2002) (106)
Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor. (1999) (105)
Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. (2000) (104)
Low-grade astrocytoma with neuraxis dissemination at diagnosis. (1995) (104)
Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. (1991) (102)
National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. (2018) (101)
Influence of tumor grade on time to progression after irradiation for localized ependymoma in children. (2002) (100)
Ewing's sarcoma: local tumor control and patterns of failure following limited-volume radiation therapy. (1991) (97)
Systematic analysis of errors in target localization and treatment delivery in stereotactic radiosurgery (SRS). (1994) (97)
Pre‐irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the pediatric oncology group, protocol 8833 (1993) (95)
Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors. (2002) (95)
Radiation therapy for incompletely resected meningiomas. (1985) (94)
Second neoplasms in pediatric patients with primary central nervous system tumors (2004) (94)
Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. (2001) (93)
MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). (2011) (92)
Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. (2007) (90)
Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma. (2002) (90)
Treatment of infants with malignant gliomas: The Pediatric Oncology Group Experience (2004) (90)
Abnormal hippocampal development in children with medulloblastoma treated with risk-adapted irradiation. (2004) (89)
Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors. (1999) (86)
Pediatric Low-Grade and Ependymal Spinal Cord Tumors (2000) (85)
Assessment of quality of life among pediatric patients with cancer (1989) (84)
Clear cell ependymoma: A clinicopathologic and radiographic analysis of 10 patients (2003) (84)
Hepatic undifferentiated (embryonal) sarcoma and rhabdomyosarcoma in children. Results of therapy (1987) (84)
Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cgy dose level of pediatric oncology group study #8495 (1991) (83)
Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy. (2013) (83)
Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. (2012) (82)
Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. The Pediatric Oncology Group. (1995) (80)
Long-term survivors of leukemia treated in infancy: factors associated with neuropsychologic status. (1992) (80)
Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy: Clinical characteristics and treatment related toxicities (1996) (78)
Temozolomide after Radiotherapy for Newly Diagnosed High-grade Glioma and Unfavorable Low-grade Glioma in Children (2006) (76)
Pediatric choroid plexus neoplasms. (1999) (76)
Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018. (2011) (76)
Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934. (2012) (75)
Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors (2013) (75)
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study (2012) (74)
Treatment of childhood germ cell tumors: Review of the St. Jude experience from 1979 to 1988 (1992) (74)
A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. (1986) (74)
Pediatric nasopharyngeal carcinoma: long term follow-up of 29 patients. (1989) (73)
Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. (2011) (73)
Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988. (1991) (73)
Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation. (2002) (72)
Serum Lactate Dehydrogenase in Childhood Neuroblastoma A Pediatric Oncology Group Recursive Partitioning Study (1992) (72)
Bithalamic Involvement Predicts Poor Outcome among Children with Thalamic Glial Tumors (1998) (72)
Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study. (2010) (72)
Abnormal timing of menarche in survivors of central nervous system tumors (2009) (70)
Effect of ionizing radiation on the human brain: white matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy. (2001) (70)
Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. (2000) (70)
Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function. (2002) (70)
Cutaneous and subcutaneous Ewing's sarcoma: an indolent disease. (2000) (70)
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors. (2004) (70)
Treatment of Children with Peripheral Primitive Neuroectodermal Tumor or Extraosseous Ewing's Tumor with Ewing's‐Directed Therapy (1998) (70)
Efficacy and feasibility of stereotactic radiosurgery in the primary management of unfavorable pediatric ependymoma. (1997) (69)
Radiation-induced bone abnormalities after bone marrow transplantation for childhood leukemia. (1994) (68)
Safe anesthesia for radiotherapy in pediatric oncology: St. Jude Children's Research Hospital Experience, 2004-2006. (2008) (68)
Maintenance of certification. (2005) (67)
High‐dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors (2008) (67)
Neuropsychologic function in children with brain tumors: III. Interval changes in the six months following treatment. (1985) (66)
Results of whole-brain irradiation for metastases from small cell carcinoma of the lung. (1980) (65)
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. (2004) (65)
Brain tumors in the very young child: Postoperative chemotherapy in combined‐modality treatment (1988) (65)
A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? (2000) (64)
Neurodevelopmental status of infants and young children treated for brain tumors with preirradiation chemotherapy. (1989) (64)
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study. (2007) (63)
Challenges with defining response to antitumor agents in pediatric neuro‐oncology: A report from the response assessment in pediatric neuro‐oncology (RAPNO) working group (2013) (62)
Phase I Trial of Single-Dose Temozolomide and Continuous Administration of O6-Benzylguanine in Children with Brain Tumors: a Pediatric Brain Tumor Consortium Report (2007) (61)
Efficacy of combined surgery and irradiation for localized Ewings sarcoma family of tumors (2004) (61)
Metastatic Ewing's sarcoma: remission induction and survival. (1987) (60)
Long-term results with radiation therapy for pediatric desmoid tumors. (2000) (59)
The effects of radiation on craniofacial skeletal growth: a quantitative study. (1998) (59)
Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelae (2007) (59)
Gliomas of the tectum and periaqueductal region of the mesencephalon. (1991) (58)
Randomized Study of Adjuvant Chemotherapy for Head and Neck Cancer (1985) (58)
Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study. (1998) (58)
Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. (1993) (57)
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas. (2010) (57)
Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system. (2012) (56)
Hepatopathy following irradiation and adriamycin (1978) (56)
Second malignancy after treatment of childhood non‐Hodgkin lymphoma (2001) (56)
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report. (2014) (56)
Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium. (2016) (55)
Ependymomas in children. (1988) (55)
Diagnosis of Malignant Lymphomas of the Nasal Cavity, Paranasal Sinuses and Nasopharynx (1983) (55)
Preradiation chemotherapy in advanced medulloblastoma a pediatric oncology group pilot study (1993) (55)
A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study (2013) (55)
Supratentorial malignant gliomas in childhood (1997) (55)
Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. (1995) (54)
Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG (2011) (53)
Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation. (2013) (53)
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study. (2012) (53)
Young age may predict a better outcome for children with diffuse pontine glioma (2008) (52)
Disease control after reduced volume conformal and intensity modulated radiation therapy for childhood craniopharyngioma. (2013) (52)
Treatment of Hodgkin's disease using intensive chemotherapy followed by irradiation. (1976) (52)
Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. (2008) (52)
Medullomyoblastoma: A radiographic and clinicopathologic analysis of six cases and review of the literature (2004) (52)
Lack of efficacy of postoperative chemotherapy and delayed radiation in very young children with pineoblastoma. Pediatric Oncology Group. (1995) (51)
Human gene marker/therapy clinical protocols. (1999) (51)
Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma (2006) (50)
Primary cerebral germinoma and ventriculoperitoneal shunt metastasis (1981) (50)
Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34. (2014) (50)
High-Grade Pediatric Spinal Cord Tumors (1999) (50)
Response of pediatric low grade gliomas to chemotherapy. (1993) (49)
Neuropsychological sequelae of childhood brain tumors: A review (1983) (48)
Paclitaxel for the Treatment of Progressive or Recurrent Childhood Brain Tumors: A Pediatric Oncology Phase II Study (2001) (47)
Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome. (1996) (47)
Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. (2008) (47)
Selective Use of Whole-Lung Irradiation for Patients With Ewing Sarcoma Family Tumors and Pulmonary Metastases at the Time of Diagnosis (2001) (47)
Survival and late mortality in long-term survivors of pediatric CNS tumors. (2007) (46)
Psychologic and Neurologic Function Following Treatment for Childhood Temporal Lobe Astrocytoma (1988) (46)
Clinically evident venous thromboembolic events in children with brain tumors. (2004) (46)
O6-Methylguanine-DNA methyltransferase protein levels in pediatric brain tumors. (1997) (45)
Bone tumors other than osteosarcoma after retinoblastoma (1993) (45)
Management and outcome of focal low-grade brainstem tumors in pediatric patients: the St. Jude experience. (2013) (44)
Malignant Evolution of Choroid Plexus Papilloma (1999) (44)
Multiple Genomic Alterations Including N-myc Amplification in a Primary Large Cell Medulloblastoma (2000) (44)
DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy (2010) (43)
Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma. (2008) (43)
Topotecan for the Treatment of Recurrent or Progressive Central Nervous System Tumors – A Pediatric Oncology Group Phase II Study (1999) (43)
Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031. (2006) (43)
Effect of therapeutic ionizing radiation on the human brain (2001) (43)
Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma. (1997) (43)
Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation. (1984) (42)
Evaluation of 18F-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain Stem Glioma: A Report from the Pediatric Brain Tumor Consortium (2011) (42)
Intensity-modulated radiation therapy for children with intraocular retinoblastoma: potential sparing of the bony orbit. (2004) (42)
Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. (1996) (42)
Results of Pediatric Oncology Group Protocol 8104 for Infants with Stages D and DS Neuroblastoma (1995) (41)
Seizures in children with primary brain tumors: Incidence and long-term outcome (2005) (41)
Total dose, fraction size, and tumor volume in the local control of Hodgkin's disease. (1988) (40)
Neonatal alveolar rhabdomyosarcoma with skin and brain metastases (2001) (40)
Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. (1994) (39)
Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy. (2015) (39)
Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients. (1995) (39)
Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T‐cell leukemia (1987) (38)
Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy. (1997) (38)
A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma (1993) (38)
Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma (2006) (38)
Neuropsychologic function in children with brain tumors: II. Serial studies of intellect and time after treatment. (1983) (37)
Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation. (2010) (37)
Complications of the nevoid basal cell carcinoma syndrome: a case report. (1997) (37)
Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long‐term outcomes (2016) (37)
Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients (2010) (36)
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study (2015) (36)
Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour. (2009) (36)
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors (2009) (35)
Local control in synchronous bilateral Wilms tumor. (1996) (35)
Effect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study† (2017) (34)
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001). (2005) (34)
Bevacizumab (BVZ)‐associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT‐11) (2013) (33)
Advances in surgical techniques for resection of childhood cerebellopontine angle ependymomas are key to survival (2009) (33)
Feasibility and efficacy of preirradiation chemotherapy for pediatric brain tumors. (1988) (33)
Phase I Trial of Intrathecal Spartaject Busulfan in Children with Neoplastic Meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004) (2006) (33)
Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma (2008) (32)
The American board of radiology perspective on maintenance of certification: part IV--practice quality improvement for diagnostic radiology. (2007) (32)
Types, causes, and outcome of intracranial hemorrhage in children with cancer. (2005) (31)
Cyclophosphamide for the treatment of progressive low-grade astrocytoma: a Pediatric Oncology Group phase II Study. (1999) (31)
Stage III nodular lymphoreticular tumors (non‐Hodgkin's lymphoma): Results of central lymphatic irradiation (1981) (31)
Intracranial germinoma: On whole‐ventricular irradiation (2005) (31)
Surveillance neuroimaging to detect relapse in childhood brain tumors: a Pediatric Oncology Group study. (2001) (31)
Peritoneal metastases in two patients with pineoblastoma and ventriculo-peritoneal shunts. (1994) (31)
Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas (2014) (31)
Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tracts. (2008) (31)
Lymphoid gene expression as a predictor of risk of secondary brain tumors (2005) (30)
Quality‐of‐Life Assessment in Cancer Patients (1988) (30)
Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific to CNS relapse and therapy. (1990) (30)
Paratesticular rhabdomyosarcoma: Delayed effects of multimodality therapy and implications for current management (1994) (30)
Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcoma. (2010) (30)
Pediatric brachytherapy. The St. Jude children's research hospital experience (1994) (30)
Neuraxis dissemination in pediatric brain tumors. Response to preirradiation chemotherapy (1992) (29)
Brain tumor therapy-induced changes in normal-appearing brainstem measured with longitudinal diffusion tensor imaging. (2012) (29)
18F-FDG PET and MR Imaging Associations Across a Spectrum of Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium (2014) (29)
Granular-cell pituicytoma associated with multiple endocrine neoplasia type. (1982) (28)
Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital. (2000) (28)
M1 Medulloblastoma: high risk at any age (2008) (28)
Irradiation of pediatric high-grade spinal cord tumors. (2010) (27)
Ocular Preservation After 36 Gy External Beam Radiation Therapy for Retinoblastoma (2002) (27)
Relation of tumor-cell ploidy to survival in children with medulloblastoma. (1993) (27)
American Board of Radiology: maintenance of certification. (2005) (26)
“Occult” post-contrast signal enhancement in pediatric diffuse intrinsic pontine glioma is the MRI marker of angiogenesis? (2014) (26)
Carboplatin‐based primary chemotherapy for infants and young children with CNS tumors (2009) (26)
A Phase II Trial of High‐Dose Methotrexate in Previously Untreated Children and Adolescents with High‐Risk Unresectable or Metastatic Rhabdomyosarcoma (1997) (26)
Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237. (2003) (25)
Patterns of involvement with malignant lymphoma and implications for treatment decision making. (1975) (25)
Hearing Loss as a Late Complication of Radiotherapy in Children with Brain Tumors (2005) (25)
A phase I study of ifosfamide given on alternate days to treat children with brain tumors (1993) (25)
The Neuroimaging Center of the Pediatric Brain Tumor Consortium-collaborative neuroimaging in pediatric brain tumor research: a work in progress. (2007) (24)
Importance of histologic condition and treatment of pediatric cerebellar astrocytoma (1991) (24)
Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001) (2012) (24)
Morbidity of Second-Look Surgery in Pediatric Central Nervous System Tumors (2001) (24)
Jaw dysfunction related to pterygoid and masseter muscle dosimetry after radiation therapy in children and young adults with head-and-neck sarcomas. (2012) (24)
Multiple causes of cerebrovascular events in children with tumors of the parasellar region (1998) (23)
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children’s oncology group (2006) (23)
Phase I Trial of VNP40101M (Cloretazine) in Children with Recurrent Brain Tumors: A Pediatric Brain Tumor Consortium Study (2008) (23)
Comparison of gallium and PET scans at diagnosis and follow‐up of pediatric patients with Hodgkin lymphoma (2008) (23)
Establishment and results of a magnetic resonance quality assurance program for the pediatric brain tumor consortium. (2008) (23)
Malignant germ cell tumors of the head and neck in childhood (1989) (23)
Quality of survival among children treated for brain stem glioma. (1994) (23)
Changes in MR signal intensity and contrast enhancement of therapeutically irradiated soft tissue. (1990) (22)
Outcome for children with high stage medulloblastoma: Results of the pediatric oncology group 9031 (2000) (22)
Effects of single-dose and fractionated cranial irradiation on rat brain accumulation of methotrexate. (1984) (22)
Medulloblastoma--caution regarding new treatment approaches. (1991) (21)
Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study. (2000) (21)
American Board of Radiology Perspective on Maintenance of Certification: Part IV--Practice Quality Improvement for Diagnostic Radiology. (2007) (21)
A phase‐1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study (2013) (21)
Cranial irradiation in acute leukemia: dose estimate in the lens. (1979) (21)
Hematologic and immunologic status in Hodgkin's disease 5 years after radical radiotherapy (1975) (21)
Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small‐cell carcinoma of the lung (1981) (20)
Exploratory Evaluation of MR Permeability with 18F-FDG PET Mapping in Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium (2013) (20)
Late outcomes of adult survivors of childhood non‐Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study (2017) (20)
Patterns of treatment failure in pediatric and young adult patients with Hodgkin's disease: local disease control with combined-modality therapy. (2005) (20)
Brain metastases in children with melanoma (1997) (20)
The role of thoracic and cranial irradiation for small cell carcinoma of the lung. (1981) (19)
A phase I pharmacokinetic trial of sonic hedgehog (SHH) antagonist GDC-0449 in pediatric patients with recurrent or refractory medulloblastoma: A Pediatric Brain Tumor Consortium study (PBTC 25). (2010) (19)
Medulloblastoma Metastatic to the Suprasellar Region at Diagnosis: A Report of Six Cases with Clinicopathologic Correlation (2002) (18)
Brain tumors. Challenges and directions. (1997) (18)
Supratentorial malignant gliomas in childhood : A single institution perspective (1997) (18)
Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia. (1995) (18)
Headaches in Children With Craniopharyngioma (2013) (18)
Doxorubicin cardiomyopathy in children with left-sided Wilms tumor. (1982) (18)
Isolated Bilateral T‐Cell Renal Lymphoblastic Lymphoma (1986) (17)
A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors (1995) (17)
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study (2014) (17)
Failure of early intensive chemotherapy to improve prognosis in childhood acute lymphocytic leukemia. (1980) (17)
Radiation therapy for children: evolving technologies in the era of ALARA (2009) (17)
Hodgkin's disease with leptomeningeal involvement: Report of a case with long survival (1984) (17)
Phase II study of 5‐fluorouracil/leucovorin for pediatric patients with malignant solid tumors (1994) (16)
American Board of Radiology: Maintenance of Certification. (2005) (16)
Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshop. (2010) (15)
A chemosensitive pediatric extraosseous osteosarcoma: case report and review of the literature. (2003) (15)
Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors. (2013) (15)
Incidental detection of late subsequent intracranial neoplasms with magnetic resonance imaging among adult survivors of childhood cancer (2014) (15)
Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC) (2008) (14)
Effect of hepatic irradiation on the toxicity and pharmacokinetics of adriamycin in children. (1981) (14)
A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia. (1995) (14)
MR imaging of infradiaphragmatic lymphadenopathy in children and adolescents with Hodgkin disease: Comparison with lymphography and CT (1993) (14)
Cerebellar pontine angle ependymoma in infants. (1997) (14)
Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk‐adapted craniospinal irradiation and adjuvant chemotherapy (2015) (14)
A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors (2015) (14)
American Board of Radiology Maintenance of Certification - Part IV: practice quality improvement for radiation oncology. (2007) (14)
A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study. (2015) (14)
Treatment planning and delivery of external beam radiotherapy for pediatric sarcoma: the St. Jude Children's Research Hospital experience. (2008) (13)
Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital. (1999) (13)
METASTATIC OSTEOSARCOMA TO THE LIVER AFTER TREATMENT FOR SYNOVIAL SARCOMA: A Case Report (2001) (13)
Clinical experience with a system for pediatric respiratory gated radiotherapy (1998) (13)
A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas (2018) (13)
A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study. (1995) (12)
Prognostic factors in pediatric Hodgkin’s disease (2001) (12)
More on surveillance of children with medulloblastoma. (1995) (12)
Response to pre-radiation chemotherapy is predictive of improved survival in high risk medulloblastoma: results from pediatric oncology group (POG 9031) (2001) (12)
A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma. (1995) (12)
Neuropsychological performance of children surviging cerebellar tumors: six case studies (1986) (12)
Effectiveness of a six‐drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children (1985) (11)
Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neck. (1991) (11)
American Board of Radiology: maintenance of certification. (2005) (11)
Importance of histologic condition and treatment of pediatric cerebellar astrocytoma. (1991) (11)
Desmoplastic infantile gangliogliomas : an approach to therapy. Comment (1994) (10)
Infectious meningitis mimicking recurrent medulloblastoma on magnetic resonance imaging. Case report. (1999) (10)
The role of second‐look surgery in the management of advanced germ cell malignancies (1991) (10)
Medulloblastoma--challenges in radiation therapy and the addition of chemotherapy. (2000) (10)
Maintenance of certification for radiation oncology. (2005) (9)
Comprar Pediatric Radiation Oncology | Edward C Halperin | 9781605472607 | Lippincott Williams & Wilkins (2010) (9)
Report of the American Society for Therapeutic Radiology and Oncology Working Group on the scope of radiation oncology (SCOPE). (2002) (9)
The American Board of Radiology perspective on maintenance of certification: part IV--practice quality improvement in diagnostic radiology. (2007) (9)
Post‐irradiation malignant mesothelioma (1997) (8)
FDG-PET/CT Prior or Subsequent to Radiation is a Poor Predictor of Local Outcome in Patients with Group III Rhabdomyosarcoma (2011) (8)
A step toward ending the controversies in Hodgkin's disease. (1989) (8)
Fatal misonidazole‐induced encephalopathy. An RTOG case report (1982) (8)
Primary perineal alveolar rhabdomyosarcoma metastatic to an extraocular muscle. (2003) (8)
A model for quantitative changes in the magnetic resonance parameters of muscle in children after therapeutic irradiation. (2006) (8)
First-in-pediatrics phase I study of crenolanib besylate (CP-868,596-26) administered during and after radiation therapy (RT) in newly diagnosed diffuse intrinsic pontine glioma (DIPG) and recurrent high-grade glioma (HGG). (2014) (8)
18 Is it time to rethink the role of hyperfractionated radiotherapy in the management of children with newly-diagnosed brainstem glioma?: Results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy (1997) (8)
MB-32FEASIBILITY OF VORINOSTAT COMBINED WITH ISOTRETINOIN AND CHEMOTHERAPY FOR YOUNG CHILDREN WITH NEWLY DIAGNOSED EMBRYONAL BRAIN TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY. (2015) (8)
DNA index of glial tumors in children: Correlation with tumor grade and prognosis (1996) (8)
Results of a prospective clinical trial for VAMP alone without irradiation for pediatric favorable, early-stage Hodgkin lymphoma patients who achieve an early complete response. (2011) (7)
Hodgkin's disease in children. (1989) (7)
105 Efficacy of supradose intra-arterial targeted (SIT) cisplatin (P) and concurrent radiation therapy (RT) in the treatment of unresectable stage III-IV head and neck (H/N) carcinoma (1995) (7)
Three-dimensional reconstruction of arteriovenous malformations from multiple stereotactic angiograms. (1996) (7)
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation (2001) (7)
Maintenance of certification. (2005) (7)
Meningeal leukemia--control versus cure. (1977) (7)
Neurocognitive effects of radiation therapy (2001) (7)
Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. (2013) (6)
Hematologic recovery and deterioration after "successful" radiotherapy for Hodgkin's disease. (1974) (6)
Hyperfractionated irradiation and concurrent cisplatin in brain stem tumors: a Pediatric Oncology Group pilot study (9139). (1994) (6)
A phase II study of every other day high-dose ifosfamide in pediatric brain tumors (2005) (6)
Local-regional non-rhabdomyosarcomatous soft tissue sarcomas of the head and neck. (1990) (6)
Interstitial Iodine 125 and Concomitant Cisplatin Followed by Hyperfractionated External Beam Irradiation for Malignant Supratentorial Glioma: Preliminary Experience at the University of Tennessee, Memphis (1993) (6)
Final results of a study of escalating doses of hyper fractionated radiotherapy in pediatric brain stem tumors (1992) (6)
Efficacy of definitive irradiation and multi-agent systemic therapy for localized ewing’s sarcoma family of tumors (ESFT) (2003) (5)
Quantitative white matter loss explains risks of young age for neurocognitive deficits in medulloblastoma survivors (2000) (5)
Pineal Region Tumors (2002) (5)
Phase I trial of the oral farnesyl protein transferase inhibitor lonafarnib (SCH66336): A Pediatric Brain Tumor Consortium (PBTC) study. (2004) (5)
Patterns of treatment failure in pediatric Hodgkin’s disease treated with combined modality therapy (2004) (5)
The American Board of Radiology perspective on maintenance of certification: Part IV--practice quality improvement in diagnostic radiology. (2007) (5)
A prospective neuropsychological evaluation of children treated with additional chemotherapy and craniospinal irradiation (CSI) following isolated central nervous system (CNS) relapse in acute lymphoblastic leukemia (ALL) (1993) (5)
Polar Spongioblastoma of the Spinal Cord: A Case Report (2006) (5)
Phase I trial of ZD1839 (Iressa™) and radiation in pediatric patients newly diagnosed with brain stem tumors or incompletely resected supratentorial malignant gliomas (2004) (5)
Cranial dose distribution. (1979) (5)
201 : Hearing Loss After Radiotherapy Alone for Pediatric Brain Tumors: The Effect of Cochlea Dose (2006) (4)
Local control in childhood rhabdomyosarcoma: analysis of radiation therapy parameters (1986) (4)
Malignant Brain Tumors Including Medulloblastoma, Embryonal Neuroectodermal Tumors, and Tumors of the Pineal Region, with a Special Discussion of the Management of Brain Tumors in Children of 3 Years and Younger (1994) (4)
Patterns of failure in treatment of stage I and II diffuse malignant lymphoid tumors. (1981) (4)
Radiation therapy. Trends in treatment. (1991) (3)
Conformal Radiation Therapy for Pediatric Ependymoma: The St. Jude Experience (2008) (3)
Postirradiation myelopathy in children (1979) (3)
The computed radiograph: a method of correlating axial tomographic images with simulation and port films. (1981) (3)
Magna-field irradiation: a note of caution. (1983) (3)
Tumors Of The Brain Stem, Cerebellum, and Fourth Ventricle (2002) (3)
A phase I clinical trial of veliparib and temozolomide in children with recurrent central nervous system tumors: A Pediatric Brain Tumor Consortium report. (2013) (3)
Wilms' tumor: reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology. (1990) (3)
Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of radiation dosimetry with change in cognitive function (2004) (2)
380Analysis of prognostic factors (PF) in the treatment of unresectable stage III–IV head and neck (H/N) squamous cell carcinoma (SCCa) using supradose intra-arterial targeted cisplatin (SIT-P) and concurrent radiation therapy (RT) (1996) (2)
Desmoplastic Infantile GangliogliomasAn Approach to Therapy (1994) (2)
A phase I trial of MK-0752 in children with recurrent or refractory CNS malignancies: A Pediatric Brain Tumor Consortium study. (2010) (2)
A knowledge-guided active model method of skull segmentation on T1-weighted MR images (2007) (2)
200: A Prospective Study of Spinal Cord Dosimetry and Neurologic Outcome for Infratentorial Ependymoma (2006) (2)
11. Soft tissue sarcomas in children (1997) (2)
Preliminary results from a phase II trial of conformal radiation therapy for localized pediatric brain tumors (2000) (2)
Development of a Queriable Database for Oncology Outcome Analysis (2008) (2)
TU‐EE‐A2‐06: Are Dosimetric Guidelines of Adult Lung Cancer for Preventing Radiation Pneumonitis Applicable to Pediatric Radiotherapy Involving Lungs? (2008) (1)
Scientific Program 20th Annual Meeting of the American Society of Pediatric Neurosurgeons (1996) (1)
Carboplatin and VP-16 in treatment of high stage medulloblastoma, pineoblastoma, and supratentorial primitive neuroectodermal tumors: A preliminary report (1992) (1)
腫瘍組織学は、平均リスクと高リスク髄芽細胞腫において無再発生存率の重要な独立予後因子である:前向き共同試験(SJMB96)の結果 (2007) (1)
Spinal Teratomas versus Hamartomas (1998) (1)
Introduction to the special issue: a tribute to the life of Raymond K. Mulhern. (2007) (1)
Retrospective results need prospective confirmation (1995) (1)
Long-term Toxicities of a Prospective Trial Delivering Limited Margin 3DCRT/IMRT in Children With Rhabdomyosarcoma (2013) (1)
168 Pediatric dorsally exophytic brain stem gliomas: Radiologic and clinicopathologic correlation (1999) (1)
Phase I trial of VNP40101M in children with recurrent brain tumors—A Pediatric Brain Tumor Consortium (PBTC) study (2007) (1)
15. Primary Malignant Lymphoma of the Central Nervous System: Results of Treatment of 11 Cases and Review of the Literature (1985) (1)
#553 Multiple genomic amplifications including N-MYC in a primary large cell medulloblastoma (1999) (1)
Phase I study of erlotinib administered concurrently with and after irradiation (RT) in the treatment of children, adolescents, and young adults with newly diagnosed intracerebral high-grade glioma (2007) (1)
2185 Long-term results of primary irradiation (RT) in treatment of supradiaphragmatic (SD) Hodgkin's disease (HD) in children and adolescents: The St. Jude experience (1997) (1)
A Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma: 5-year Disease Control and Functional Outcomes (2007) (1)
PDCT-10. FIRST IN PEDIATRICS PHASE I STUDY OF CRENOLANIB BESYLATE (CP-868,596-26) ADMINISTERED DURING AND AFTER RADIATION THERAPY (RT) IN NEWLY-DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND RECURRENT HIGH GRADE GLIOMA (HGG) (2016) (1)
Breast cancer after treatment for pediatric Hodgkin’s disease is most common in girls with early stage (2001) (1)
169 The influence of histology on time to progression after irradiation for localized ependymoma in pediatric patients (1999) (1)
Doxorubicin-vincristine therapy for Wilms' tumor: a pilot study. (1982) (1)
Factors associated with outcome following isolated meningeal relapse treated with craniospinal irradiation in childhood acute lymphoblastic leukemia (1991) (1)
Late Outcomes of Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) Diagnosed Between 1963-2002: A Report from the St. Jude Lifetime (SJLIFE) Cohort Study (2014) (1)
Preoperative radiation therapy of adenocarcinoma of the endometrium (1980) (1)
Outcome with central nervous system involvement at diagnosis in childhood acute nonlymphoblastic leukemia (1992) (1)
Evaluation of local control with selective use of low-dose irradiation following induction/preoperative chemotherapy for locally advanced rhabdomyosarcoma (1993) (1)
Results from a phase II trial of conformal radiation therapy for pediatric patients with localized low-grade astrocytoma and quantification of radiation-related CNS effects. (2004) (1)
Radiation Pneumonitis of Pediatric Patients with Sarcoma and Hodgkin's Lymphoma: A DVH Analysis (2008) (1)
202 : Early Results of a Prospective Study Delivering Limited Margin Radiotherapy for Pediatric Non-Rhabdo-Soft Tissue Sarcomas (NRSTS) and Aggressive Fibromatoses (AF) (2006) (1)
Phase I Trial of VNP 40101 M ( Cloretazine ) in Childrenwith Recurrent BrainTumors : A Pediatric BrainTumor Consortium Study (2008) (0)
M1 medulloblastoma should be considered high risk at any age (2007) (0)
Development and Characterization of Human Ependymoma Xenograft HxBrS 1 (2006) (0)
Human gene marker/therapy clinical protocols. (2000) (0)
End Results of a Prospective Clinical Trial with VAMP and Low-Dose, Involved-Field Radiation for Pediatric Patients with Favorable, Early-Stage Hodgkin’s Disease (2005) (0)
Immediate N eurocognitive E ffects o f M ethylphenidate o n Learning-Impaire d S urvivors o f C hildhood C ancer (2001) (0)
204: Secondary Bone and Soft Tissue Sarcomas In Children Treated for Hodgkin Lymphoma (2006) (0)
Wilm's tumor: analysis of reduced dose radiotherapy in stage iii abdominal disease with favorable histology (1989) (0)
High dose hyperfractionated craniospinal irradiation (HF-CSI): Feasibility, acute toxicity, outcome and late sequelae (1998) (0)
317Interstitial I-125 implantation of malignant gliomas (1996) (0)
malignancy after etoposide treatment Granulocyte colony-stimulating factor and the risk of secondary myeloid (2013) (0)
Guidelines for Submission of Spontaneous Regression of Childhood Gliomas (2004) (0)
CLIN-PEDIATRICS CLINICAL RESEARCH (2012) (0)
Leukemia Central Nervous System Relapse in Children With Acute Lymphoblastic Early Intensification of Intrathecal Chemotherapy Virtually Eliminates (2013) (0)
Long-Term Memory Deficits and Early Onset Dementia in Aging Adult Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Cranial Irradiation (2012) (0)
Uniformity of FDG uptake in pediatric brain stem gliomas predicts survival (2009) (0)
Registration of MR permeability and FDG uptake in pediatric brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC) (2012) (0)
Treatment of tumors of the brain. (1978) (0)
407 Radiotherapy for pediatric brain tumors standard of care, current clinical trials and new directions (1996) (0)
Systematic analysis of target localization and treatment delivery uncertainties in stereotactic radiosurgery (SRS) (1992) (0)
Endocrine outcome for children with embryonal brain tumors treated with craniospinal irradiation on the SJMB96 trial (2007) (0)
Local tumor control in adenoid cystic carcinomas (1981) (0)
Second malignancies after pediatric Hodgkin lymphoma: Associations with radiation dose and volume (2004) (0)
Pediatric craniopharyngiomas: analysis of functional outcome by extent of surgery and radiotherapy (1992) (0)
Electron beam therapy in children. (1991) (0)
Medulloblastoma—A model system for radiation oncology (1998) (0)
Dose distribution in cranial irradiation (1978) (0)
Long-term Cerebral Glucose Distribution in Craniopharyngioma, Ependymoma, and Low-Grade Astrocytoma Patients After Radiation Therapy (2015) (0)
PC-01. PHASE I AND PHARMACOKINETIC TRIAL OF PTC299 IN PEDIATRIC PATIENTS WITH REFRACTORY OR RECURRENT CNS TUMORS: A PBTC STUDY (2012) (0)
A Discussion of the Influence of Histology on the Treatment Selection and Prognosis of Hodgkin’s Disease and Malignant Lymphomas (1974) (0)
Saturday, May 10, 2003 (S84-S102) (2003) (0)
Introduction to the Special Issue: A Tribute to the Life of Raymond (2007) (0)
Late outcomes among adult survivors of childhood non-Hodgkin lymphoma (NHL): A report from the St. Jude Lifetime Cohort Study. (2015) (0)
Evaluation of irradiation schemes for children with rhabdomyosarcoma (RMS) (1992) (0)
BRAIN TUMORS IN INFANTS. AUTHORS REPLY (1993) (0)
Secondary neoplasms -- defining the problems and implications for therapy (1997) (0)
599Feasibility of accelerated radiotherapy (AR) using a concomitant boost in the treatment of unresectable non-small cell lung cancer (NSCLC): A phase II study (1996) (0)
Surveillance N euroimaging t o D etect R elapse i n C hildhood Brain T umors: A P ediatric O ncology G roup S tudy (2001) (0)
657 Hypothyroidism After Childhood Tumors (1996) (0)
Common malignant tumors in children (1987) (0)
Automated image registration using region matching for cranial radiotherapy (2001) (0)
Comparisons of Radiographic and Clinical Definitions of Disease Progression in Pediatric Patients with Newly Diagnosed Intrinsic Diffuse Brainstem Gliomas (BSG) Treated on a PBTC Phase II trial of Tipifarnib and Radiation (2010) (0)
Role of amifostine as a cytoprotectant in children ≥ 3 years with average risk (AR) medulloblastoma (MB) treated with craniospinal irradiation (CSI) and 4 courses of cisplatin (CDDP)-based high dose chemotherapy. (2006) (0)
RETROSPECTIVE RESULTS NEED PROSPECTIVE CONFIRMATION. AUTHOR'S REPLIES (1995) (0)
Results of radiation therapy for retinoblastoma in children less than one year old (1989) (0)
Childhood Cancers: Overview (2011) (0)
2246 Cutaneous and subcutaneous Ewing's sarcoma—A relatively indolent disease (1999) (0)
Concomitant cisplatin and I125 interstitial implantation followed by hyperfractionated external beam irradiation (HEBI) for primary supratentorial malignant gliomas (1991) (0)
308Retrospective analysis of pediatric oligodendroglioma: St. Jude experience (1996) (0)
CNS disease at diagnosis: a continuing challenge in childhood lymphoblastic leukemia. (1996) (0)
Functional status of children treated for brain tumors (1981) (0)
#415 High-dose chemotherapy and peripheral blood stem cell rescue following craniospinal irradiation is feasible for patients for medulloblastoma (1999) (0)
Contents, Vol. 22, 1995 (1985) (0)
High-Dose Methotrexate, Ifosfamide, Etoposide and Dexamethasone (MIED) Is an Active Salvage Regimen for Children with Recurrent or Refractory Malignant Lymphoma. (2007) (0)
Radiotherapy for unresectable or marginally resectable osteosarcoma (1999) (0)
Cutaneoes and subcutaneous Ewing's sarcoma — A relatively indolent disease (1999) (0)
#601 Topotecan for the treatment of recurrent or progressive CNS tumors‐a POG phase II study (1998) (0)
172 Second malignant neoplasms in children treated for hodgkin's disease (1999) (0)
Subject Index Vol. 20, 1994 (1994) (0)
Prognostic F actors f or C hildren W ith H odgkin's D isease Treated W ith C ombined-Modalit y T herapy (2003) (0)
Subject Index Vol. 20, 1994 (1994) (0)
EP-001. CENTRAL NERVOUS SYSTEM TUMORS IN CHINESE CHILDREN UNDER THE AGE OF THREE: A POPULATION STUDY BY THE HONG KONG PAEDIATRIC HAEMATOLOGY/ ONCOLOGY STUDY GROUP EP-002. SUBSEQUENT NEOPLASMS IN SURVIVORS OF CENTRAL NERVOUS SYSTEM TUMORS: RISK AFTER MODERN MULTI-MODAL THERAPY (2014) (0)
Treatment o f I ntraocular R etinoblastoma W ith V incristine and C arboplatin (2003) (0)
Growth H ormone R eplacement T herapy i n C hildren W ith Medulloblastoma: U se a nd E ffect o n T umor C ontrol (2001) (0)
Subject Index Vol. 22, 1995 (1995) (0)
President's categorical course—Tumors of the central nervous system (1998) (0)
Risks o f Y oung A ge f or S elected N eurocognitive D eficits i n Medulloblastoma A re A ssociated W ith W hite M atter L oss (2001) (0)
2143 Feasibility of accelerated radiotherapy (AR) using a concomitant boost for the treatment of unresectable non-small cell lung cancer (NSCLC): A phase II study (1996) (0)
Non-Rhabdomyosarcoma Soft Tissue Sarcoma in Pediatric and Young Adult Patients: Results From a Prospective Study Using Limited Margin Radiation Therapy (2016) (0)
Survival a nd N eurodevelopment al O utcome o f Y oung Children W ith M edulloblastoma a t S t J ude C hildren's Research H ospital (1999) (0)
CRAN-21. PHASE II STUDY OF PEGINTERFERON ALFA-2b (PEGINTRON)/SYLATRON FOR PEDIATRIC PATIENTS WITH PROGRESSIVE OR RECURRENT CRANIOPHARYNGIOMA FOLLOWING RADIOTHERAPY: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC-039) (2018) (0)
Toward magnetic resonance (MR) simulation: A knowledge-guided active-model method of skull segmentation for generating MR digitally reconstructed radiographs (DRRs) (2006) (0)
82 Efficacy of radiation therapy in the local control of synchronous bilateral Wilms Tumor (1995) (0)
Tumor location and neurocognitive impairment in adult survivors of pediatric brain tumors: A report from the St. Jude Lifetime Cohort (SJLIFE). (2012) (0)
RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY (RAPNO): CURRENT PRACTICE AND ISSUES (2012) (0)
Introduction to the Special Issue : A Tribute to the Life of Raymond K . (2007) (0)
What is the incidence of stroke in survivors of childhood Hodgkin's disease? (2006) (0)
Hypothalamic Obesity is due to Insulin Hypersecretion: Reversal With Octreotide • 455 (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Larry E. Kun?

Larry E. Kun is affiliated with the following schools:

University of Alberta
Wake Forest University
Stanford University
Deakin University
University of Tennessee Health Science Center
New York University
Duke University

Larry E. Kun's Academic­Influence.com Rankings

Larry E. Kun's Degrees

Why Is Larry E. Kun Influential?

Larry E. Kun's Published Works

Published Works

What Schools Are Affiliated With Larry E. Kun?

Larry E. Kun's AcademicInfluence.com Rankings